AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 63(5), 2000, pp. 274-279
Copyright © 2000 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouchaud, O
Right arrow Articles by Gentilini, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouchaud, O
Right arrow Articles by Gentilini, M
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 63, Issue 5, 274-279
Copyright © 2000 by American Society of Tropical Medicine and Hygiene

Research Articles


Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial

O Bouchaud, E Monlun, K Muanza, A Fontanet, T Scott, A Goetschel, JD Chulay, J Le Bras, M Danis, M Le Bras, JP Coulaud, and M Gentilini

In endemic zones, the atovaquone-proguanil (AP) combination is well tolerated and effective in treating acute, uncomplicated malaria. Trials involving non-immune patients are lacking, however. We conducted a randomized, multicenter open-label trial to determine the efficacy and tolerability of the AP combination (1,000 mg + 400 mg once daily for 3 days) in comparison with halofantrine (HF) (1,500 mg in 3 doses) in non-immune adults with imported uncomplicated Plasmodium falciparum malaria. Follow-up visits were programmed on Days 7, 14, 21, 28, and 35 after hospital discharge. Out of 48 patients enrolled in the study, 41 were assessable for the cure rate (21 in the AP group and 20 in the HF group). All the patients were cured. The mean parasite clearance time was longer (63+/-23 hours) in the AP group than in the HF group (48+/-15 hours) (P = 0.02). The frequency of gastrointestinal adverse events was higher in the AP group. No noteworthy electrocardiographic changes were observed, particularly in the QTc interval. The AP combination appears to be a valuable alternative treatment in non-immune adults.


This article has been cited by other articles:


Home page
 JAMAHome page
K. S. Griffith, L. S. Lewis, S. Mali, and M. E. Parise
Treatment of Malaria in the United States: A Systematic Review
JAMA, May 23, 2007; 297(20): 2264 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. K. BOGGILD, M. E. PARISE, L. S. LEWIS, and K. C. KAIN
ATOVAQUONE-PROGUANIL: REPORT FROM THE CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS (II)
Am J Trop Med Hyg, February 1, 2007; 76(2): 208 - 223.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
F. Marra, J. R Salzman, and M. H. Ensom
Atovaquone-Proguanil for Prophylaxis and Treatment of Malaria
Ann. Pharmacother., September 1, 2003; 37(9): 1266 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Aubouy, S. Jafari, V. Huart, F. Migot-Nabias, J. Mayombo, R. Durand, M. Bakary, J. Le Bras, and P. Deloron
DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy
J. Antimicrob. Chemother., July 1, 2003; 52(1): 43 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. L. Baggish and D. R. Hill
Antiparasitic Agent Atovaquone
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1163 - 1173.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society of Tropical Medicine and Hygiene.